Prostatitis and Prostate Cancer: What Your PSA Test Means, What Symptoms Require Evaluation, and the Screening Debate

The prostate is a walnut-sized gland that sits below the bladder in men, surrounding the urethra. Its primary function is producing prostatic fluid — a component of semen. After age 40, it becomes a significant health monitoring priority.

The Four Conditions

Acute bacterial prostatitis: Rapid onset of severe pelvic pain, fever, urinary difficulty. Medical emergency. Responds to antibiotics but requires prompt evaluation.

Chronic bacterial prostatitis: Recurrent urinary tract infections with similar but less severe symptoms. Bacterial cause confirmed by culture. Antibiotic treatment, often extended.

Chronic prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS): The most common form — affecting up to 10% of men. Pelvic pain, urinary difficulty, sexual dysfunction. No bacterial cause identified. Management involves pelvic floor physical therapy, alpha-blockers, anti-inflammatory diet. Not life-threatening, but significantly impairs quality of life. Conventional antibiotic treatment does not help CP/CPPS.

Benign Prostatic Hyperplasia (BPH): Age-related prostate enlargement. No malignant cells. Produces urinary symptoms — hesitancy, weak stream, nocturia — as the enlarged gland compresses the urethra. Requires management but is not cancer.

The PSA Test

PSA (Prostate-Specific Antigen) is a protein produced by both normal and cancerous prostate cells and is measurable in blood.

Reference ranges:

• Under 50: <2.5 ng/mL typical
• 50–59: <3.5 ng/mL
• 60–69: <4.5 ng/mL
• 70+: <6.5 ng/mL

What elevates PSA beyond cancer:

• BPH (very common and non-cancerous)
• Acute bacterial prostatitis (often markedly elevated)
• Ejaculation within 48 hours of testing
• Vigorous cycling or prostate trauma

PSA velocity — the rate of change across successive measurements — is more diagnostically useful than any single value. A slow, gradual rise over years is less concerning than the same absolute number reached quickly.

> 📌 A 2009 systematic review in the Annals of Internal Medicine found that PSA screening reduces prostate cancer mortality by 20–50% in randomized studies — but produces significant overdiagnosis and overtreatment of clinically insignificant cancer, with approximately 48 men identified and potentially treated for every death prevented at 9-year follow-up.[1]

When to Seek Immediate Evaluation

• Blood in urine or semen (hematuria, hematospermia)
• Severe pelvic, perineal, or lower back pain with fever
• Sudden inability to urinate
• PSA rise of >1 ng/mL within a single year
• Rectal exam findings of firmness, nodularity, or asymmetry

---